Neurology Specific Literature Search   
 
[home][thesaurus]
    

Enter your terms
above and click
the 'Search' button.
Showing articles 0 to 50 of 420 Next >>

Filter Applied: MRI (Click to remove)

West Nile Virus Infection in the United States
Arch Neurol 61:1190-1195, Tyler,K.L., 2004

Encephalitis Complicating Smallpox Vaccination
Arch Neurol 60:925-928, Miravalle,A. &Roos,K.L., 2003

Neurologic Manifestations and Outcome of West Nile Virus Infection
JAMA 290:511-515,524,558, Sejvar,J.J.,et al, 2003

Clinicopath Conf., Meningencephalitis and Sepsis Due to Neisseria Meningitidis Infection
NEJM 349:2341-2349, Case 38-2003, 2003

Neurologic Complications of the Reactivation of Varicella-Zoster Virus
NEJM 342:635-645, Gilden,D.H.,et al, 2000

Syndrome of Cerebral Spinal Fluid Hypovolemia
Neurol 55:1321-1327, Chung,S.J.,et al, 2000

Clinicopath Conf,Wegener's Granulomatosis with Pachymeningeal Granulomatous Inflammation, Case 9-1999
NEJM 340:945-953, , 1999

Adult-Onset Temporal Lobe Epilepsy Associated with Smoldering Herpes Simplex 2 Infection
Neurol 48:425-430, Cornford,M.E.&McCormick,G.F., 1997

Childhood Leukemia:Central Nervous System Abnormalities During and After Treatment
AJNR 17:295-310, Chen,C-Y.,et al, 1996

Clinicopath Conf
Subacute Bacterial Endocarditis with Multiple Cerebral Emboli and Mycotic Aneurysm, Case 10-1993, NE, M 8:717-725,1993., 1993

New-Onset Seizures Associated with Human Immunodeficiency Virus Infection: Causation and Clinical Features in 100 Cases
Am J Med 87:173-177, Holtzman, D.M.,et al, 1989

Automated Idiopathic Normal Pressure Hydrocephalus Diagnosis via Artificial Intelligence-Based 3D T1 MRI Volumetric Analysis
AJNR 46:33-40, Lee,J.,et al, 2025

Clinicopathologic conference, Malignant Mixed Germ-Cell Tumor and Anti-NMDA Receptor Encephalitis
NEJM 303:488-496, Case 22-2025, 2025

Clinical Evaluation of a 2-Minute Ultrafast Brain MR Protocol for Evaluation of Acute Pathology in the Emergency and Inpatient Settings
AJNR 45:379-385, Lang,M.,et al, 2024

Forensic Neurology:Practice Considerations and Training Opportunities
Neurol 103:e209560, Zheng,D.,et al, 2024

Bornavirus Encephalitis Shows a Characteristic Magnetic Resonance Phenotype in Humans
Ann Neurol 88:723-735, Finck, T.,et al, 2020

Varicella-Zoster Virus-Related Hemorrhagic Encephalomyelitis
Neurol 90:e1360-e1361, Ganesh, A.,et al, 2018

Magnetic Resonance Imaging Selection for Endovascular Stroke Therapy
Stroke 49:1402-1406, Simonsen, C.Z.,et al, 2018

Management of Acute Retinal Ischemia
Ophthalmol 125:1597-1607, Viousse, V.,et al, 2018

Non-Specific Low Back Pain
Lancet 389:736-747, Maher, C.,et al, 2017

Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator
NEJM 376:755-764, Russo, R.J.,et al, 2017

Myelopathy in Behcets Disease: The Bagel Sign
Ann Neurol 82:288-298, Uygunoglu, U.,et al, 2017

Paraneoplastic and Autoimmune Encephalitis
UptoDate July, Dalmau, J.,et al, 2017

Pacemakers in MRI for the Neuroradiologist
AJNR 38:2222-2230, Korutz, A.W.,et al, 2017

Safety of Magnetic Resonance Imaging in Patients with Cardiac Devices
NEJM 377:2555-2564, Nazarian, S.,et al, 2017

Superior MRI Outcomes with Alemtuzumab Compared with Subcutaneous Interferon �-1a in MS
Neurol 87:1464-1472, Arnold, D.L.,et al, 2016

Spectrum of Imaging Appearances of Intracranial Cryptococcal Infection in HIV/AIDS Patients in the Anti-Retroviral Therapy Era
Clin Radiol 71:9-17, Offiah, C.E. & Naseer, A., 2016

Paraneoplastic Cerebellar Degeneration with Anti-Yo Antibodies - A Review
Ann Clin Trans Neurol 3:655-663, Venkatraman,A. & Opal,P., 2016

Screening with MRI for Accurate and Rapid Stroke Treatment
Neurol 84:2438-2444, 2394, Shah, S.,et al, 2015

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
NEJM 373:1418-1428, Kappos, L.,et al, 2015

Making Sense of Sellar Region Pathology:Image-Based Diagnostic Algorighm
Contemp Diag Radiol 38:1-7, Chaudhry,A.A.,et al, 2015

Addition of Hyperacute MRI Aids in Patient Selection, Decreasing the Use of Endovascular Stroke Therapy
Stroke 45:467-472, Wisco, D.,et al, 2014

Safety and Efficacy of Ofatumumab in Relapsing-Remitting Multiple Sclerosis
Neurol 82:573-581, Sorensen, P.S.,et al, 2014

Clinical Characteristics and Outcome of Brain Abscess
Neurol 82:806-813, Brouwer, M.C.,et al, 2014

Magnetic Resonance Imaging Screening to Identify Spinal and Paraspinal Infections Associated with Injections of Contaminated Methylprednisolone Acetate
JAMA 309:2465-2472, Malani, A.,et al, 2013

Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:2167-2175, Gold, R.,et al, 2013

Revised Diagnostic Criteria for the Pseudotumor Cerebri Syndrome in Adults and Children
Neurol 81:1159-1165, Friendman, D.I.,et al, 2013

Cerebral Amyloid Angiopathy
eMedicine, Jan, Menon, R.S., 2012

Characteristics of Intravascular Large B-Cell Lymphoma on Cerebral MR Imaging
AJNR 33:292-296, Yamamoto,A.,et al, 2012

Natalizumab-Associated PML Identified in the Presymptomatic Phase Using MRI Surveillance
Neurol 78:507-508, Blair,N.F.,et al, 2012

Update on the Pathophysiology and Management of Idiopathic Intracranial Hypertension
JNNP 83:488-494, Biousse,V.,et al, 2012

Autoimmune Epilepsy
Arch Neurol 69:582-593,565, Quek, A.M.L.,et al, 2012

Acute Stroke Imaging: CT with CT Angiography and CT Perfusion before Management Decisions
AJNR 33:792-794, Fox, A.J.,et al, 2012

Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients with Multiple Sclerosis
Arch Neurol 69:1259-1269, Radue, E.W.,et al, 2012

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
NEJM 367:1098-1106,1149, Gold, R.,et al, 2012

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
NEJM 367:1087-1097,1149, Fox, R.J.,et al, 2012

Should we be nervous about coeliac disease? Brain abnormalities in patients with coeliac disease referred for neurologic opinion
JNNP 83:1216-1221, Currie, S.,et al, 2012

Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:1158-1192, Saposnik,G.,et al, 2011

Mechanisms of Fingolimods Efficacy and Adverse Effects in Multiple Sclerosis
Ann Neurol 69:759-777, Cohen, J.A. & Chun, J., 2011



Showing articles 0 to 50 of 420 Next >>